{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:54:10Z","timestamp":1790463250111,"version":"4.1.0"},"reference-count":103,"publisher":"Impact Journals, LLC","issue":"41","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,11]]},"DOI":"10.18632\/oncotarget.11960","type":"journal-article","created":{"date-parts":[[2016,9,11]],"date-time":"2016-09-11T03:29:27Z","timestamp":1473564567000},"page":"66360-66385","source":"Crossref","is-referenced-by-count":54,"title":["Noncanonical SQSTM1\/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming"],"prefix":"10.18632","volume":"7","author":[{"given":"Irene","family":"Riz","sequence":"first","affiliation":[{"name":"Department of Anatomy and Regenerative Biology, George Washington University, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S.","family":"Hawley","sequence":"additional","affiliation":[{"name":"Flow Cytometry Core Facility, George Washington University, Washington, DC, USA"},{"name":"Flow Cytometry Core, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Marsal","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Regenerative Biology, George Washington University, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Hawley","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Regenerative Biology, George Washington University, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: diagnosis and treatment","volume":"91","author":"Kumar","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0801479","article-title":"Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma","volume":"359","author":"Schots","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood-2010-02-268862","article-title":"Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma","volume":"116","author":"Vesole","year":"2010","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/bs.acr.2015.03.002","article-title":"Emerging therapeutic strategies for overcoming proteasome inhibitor resistance","volume":"127","author":"Dolloff","year":"2015","journal-title":"Adv Cancer Res"},{"key":"5","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.18632\/oncotarget.1497","article-title":"Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms","volume":"4","author":"Chang","year":"2013","journal-title":"Oncotarget"},{"key":"6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1039\/c3np20126k","article-title":"From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes","volume":"30","author":"Crews","year":"2013","journal-title":"Nat. Prod. Rep"},{"key":"7","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/1078-0432.CCR-13-0755","article-title":"U.S. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma","volume":"19","author":"Adams","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood-2012-05-425934","article-title":"A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma","volume":"120","author":"Reu","year":"2012","journal-title":"Blood"},{"key":"9","article-title":"Design and rationale of FOCUS (PX-171-011): a randomized, open-label, phase 3 study of carfilzomibbest supportive care regimen in patients with relapsed and refractory multiple myeloma (R\/R MM)","volume":"12","author":"Ludwig","year":"2012","journal-title":"BMC Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajh.23387","article-title":"Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1","volume":"88","author":"Hawley","year":"2013","journal-title":"Am. J. Hematol"},{"key":"11","doi-asserted-by":"publisher","first-page":"14814","DOI":"10.18632\/oncotarget.4530","article-title":"KLF4-SQSTM1\/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models","volume":"6","author":"Hawley","year":"2015","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1111\/febs.13540","article-title":"p62\/SQSTM1 functions as a signaling hub and an autophagy adaptor","volume":"282","author":"Komatsu","year":"2015","journal-title":"FEBS J"},{"key":"13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Iemura","year":"2010","journal-title":"Nat Cell Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","article-title":"p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription","volume":"285","author":"Johansen","year":"2010","journal-title":"J. Biol. Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Dinkova-Kostova","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.molmed.2016.05.002","article-title":"The dual roles of NRF2 in cancer","volume":"22","author":"Giordano","year":"2016","journal-title":"Trends Mol Med"},{"key":"17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jnutbio.2015.08.001","article-title":"The complexity of the Nrf2 pathway: beyond the antioxidant response","volume":"26","author":"Kong","year":"2015","journal-title":"J. Nutr. Biochem"},{"key":"18","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Yamamoto","year":"2004","journal-title":"Mol. Cell. Biol"},{"key":"19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","article-title":"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1","volume":"26","author":"Yamamoto","year":"2006","journal-title":"Mol. Cell. Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1305687110","article-title":"Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex","volume":"110","author":"Dinkova-Kostova","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/nar\/gkp1048","article-title":"An internal ribosomal entry site mediates redox-sensitive translation of Nrf2","volume":"38","author":"Kong","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1124\/mol.107.035360","article-title":"Translational control of Nrf2 protein in activation of antioxidant response by oxidants","volume":"72","author":"Chen","year":"2007","journal-title":"Mol Pharmacol"},{"key":"23","article-title":"La autoantigen mediates oxidant induced de novo Nrf2 protein translation","volume":"11","author":"Chen","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bbamcr.2012.04.002","article-title":"Cap-independent Nrf2 translation is part of a lipoic acid-stimulated detoxification stress response","volume":"1823","author":"Hagen","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbrc.2013.06.052","article-title":"Translational control of Nrf2 within the open reading frame","volume":"437","author":"Merali","year":"2013","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"26","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1128\/MCB.23.20.7198-7209.2003","article-title":"Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival","volume":"23","author":"Diehl","year":"2003","journal-title":"Mol. Cell. Biol"},{"key":"27","doi-asserted-by":"crossref","first-page":"20108","DOI":"10.1074\/jbc.M314219200","article-title":"PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress","volume":"279","author":"Diehl","year":"2004","journal-title":"J. Biol. Chem"},{"key":"28","doi-asserted-by":"crossref","first-page":"e1001945","DOI":"10.1371\/journal.pbio.1001945","article-title":"De-differentiation confers multidrug resistancenoncanonical PERK-Nrf2 signaling","volume":"12","author":"Gupta","year":"2014","journal-title":"PLoS Biol"},{"key":"29","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2337\/db15-1324","article-title":"Role of GCN2-independent signaling through a noncanonical PERK\/NRF2 pathway in the physiological responses to dietary methionine restriction","volume":"65","author":"Gettys","year":"2016","journal-title":"Diabetes"},{"key":"30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1158\/1078-0432.CCR-13-3239","article-title":"Molecular pathways: the PERKs and pitfalls of targeting the unfolded protein response in cancer","volume":"21","author":"Diehl","year":"2015","journal-title":"Clin Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/16729","article-title":"Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase","volume":"397","author":"Ron","year":"1999","journal-title":"Nature"},{"key":"32","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1097-2765(00)80330-5","article-title":"Perk is essential for translational regulation and cell survival during the unfolded protein response","volume":"5","author":"Ron","year":"2000","journal-title":"Mol Cell"},{"key":"33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1083\/jcb.200408003","article-title":"Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response","volume":"167","author":"Ron","year":"2004","journal-title":"J Cell Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1128\/MCB.00221-14","article-title":"Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition","volume":"34","author":"Itoh","year":"2014","journal-title":"Mol. Cell. Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"20858","DOI":"10.1074\/jbc.M101198200","article-title":"Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation","volume":"276","author":"Alam","year":"2001","journal-title":"J. Biol. Chem"},{"key":"36","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.bbamcr.2012.06.001","article-title":"Implication of Nrf2 and ATF4 in differential induction of CHOP by proteasome inhibition in thyroid cancer cells","volume":"1823","author":"Wang","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"37","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1073\/pnas.1216862110","article-title":"eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition","volume":"110","author":"Borden","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"38","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1038\/ncomms6413","article-title":"MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL","volume":"5","author":"Becker","year":"2014","journal-title":"Nat Commun"},{"key":"39","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V73.4.1020.1020","article-title":"The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation","volume":"73","author":"Coda","year":"1989","journal-title":"Blood"},{"key":"40","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1093\/nar\/gks409","article-title":"Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha","volume":"40","author":"Bell","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1093\/nar\/gkq212","article-title":"Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis","volume":"38","author":"Biswal","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"42","first-page":"120305","article-title":"Novel hematopoietic target genes in the NRF2-mediated transcriptional pathway","volume":"2013","author":"Bell","year":"2013","journal-title":"Oxid. Med. Cell. Longev"},{"key":"43","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Mesirov","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"44","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1534\/g3.112.003202","article-title":"oPOSSUM-3: advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets","volume":"2","author":"Wasserman","year":"2012","journal-title":"G3 (Bethesda)"},{"key":"45","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1038\/srep07201","article-title":"HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction","volume":"4","author":"Bae","year":"2014","journal-title":"Sci Rep"},{"key":"46","doi-asserted-by":"crossref","first-page":"4148791","DOI":"10.1155\/2016\/4148791","article-title":"NRF2 regulates HER2 and HER3 signaling pathway to modulate sensitivity to targeted immunotherapies","volume":"2016","author":"Deeni","year":"2016","journal-title":"Oxid. Med. Cell. Longev"},{"key":"47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ncb2738","article-title":"ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death","volume":"15","author":"Kaufman","year":"2013","journal-title":"Nat Cell Biol"},{"key":"48","doi-asserted-by":"crossref","first-page":"e10755","DOI":"10.1371\/journal.pone.0010755","article-title":"Eef1a2 promotes cell growth, inhibits apoptosis and activates JAK\/STAT and AKT signaling in mouse plasmacytomas","volume":"5","author":"Morse","year":"2010","journal-title":"PLoS One"},{"key":"49","doi-asserted-by":"crossref","first-page":"35287","DOI":"10.1074\/jbc.M109.050120","article-title":"RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation","volume":"284","author":"Ridley","year":"2009","journal-title":"J. Biol. Chem"},{"key":"50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2007.06.021","article-title":"The endoplasmic reticulum stress-inducible protein Niban regulates eIF2\u03b1 and S6K1\/4E-BP1 phosphorylation","volume":"360","author":"Hino","year":"2007","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"51","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4161\/auto.7.10.15904","article-title":"GABARAPL1 (GEC1): original or copycat?","volume":"7","author":"Boyer-Guittaut","year":"2011","journal-title":"Autophagy"},{"key":"52","doi-asserted-by":"crossref","first-page":"W74","DOI":"10.1093\/nar\/gkr355","article-title":"ConTra v2: a tool to identify transcription factor binding sites across species, update 2011","volume":"39","author":"De Bleser","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature09204","article-title":"Network organization of the human autophagy system","volume":"466","author":"Harper","year":"2010","journal-title":"Nature"},{"key":"54","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/emboj.2010.74","article-title":"LC3 and GATE-16\/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis","volume":"29","author":"Elazar","year":"2010","journal-title":"EMBO J"},{"key":"55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Agam","year":"2016","journal-title":"Autophagy"},{"key":"56","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/toxsci\/kfr183","article-title":"Beneficial role of Nrf2 in regulating NADPH generation and consumption","volume":"123","author":"Klaassen","year":"2011","journal-title":"Toxicol Sci"},{"key":"57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/BJ20130863","article-title":"Nrf2 affects the efficiency of mitochondrial fatty acid oxidation","volume":"457","author":"Dinkova-Kostova","year":"2014","journal-title":"Biochem J"},{"key":"58","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Czaja","year":"2009","journal-title":"Nature"},{"key":"59","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/0008-5472.CAN-14-2676","article-title":"Targeting mitochondria with avocatin B induces selective leukemia cell death","volume":"75","author":"Datti","year":"2015","journal-title":"Cancer Res"},{"key":"60","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1523\/JNEUROSCI.3590-07.2007","article-title":"Rapid activation of antioxidant defenses by nerve growth factor suppresses reactive oxygen species during neuronal apoptosis: evidence for a role in cytochrome c redistribution","volume":"27","author":"Franklin","year":"2007","journal-title":"J Neurosci"},{"key":"61","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","article-title":"Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells","volume":"1807","author":"Wu","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"62","doi-asserted-by":"crossref","first-page":"e0142438","DOI":"10.1371\/journal.pone.0142438","article-title":"NRF2 regulates PINK1 expression under oxidative stress conditions","volume":"10","author":"Sakaguchi","year":"2015","journal-title":"PLoS One"},{"key":"63","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1038\/onc.2012.493","article-title":"Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity","volume":"32","author":"Schafer","year":"2013","journal-title":"Oncogene"},{"key":"64","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1124\/mol.62.5.1001","article-title":"Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress","volume":"62","author":"Kim","year":"2002","journal-title":"Mol Pharmacol"},{"key":"65","doi-asserted-by":"crossref","first-page":"e08153","DOI":"10.7554\/eLife.08153","article-title":"Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits","volume":"4","author":"Weissman","year":"2015","journal-title":"Elife"},{"key":"66","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1038\/onc.2012.512","article-title":"Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK","volume":"32","author":"Aguirre-Ghiso","year":"2013","journal-title":"Oncogene"},{"key":"67","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1021\/ml400228e","article-title":"Discovery of GSK2656157: an optimized PERK inhibitor selected for preclinical development","volume":"4","author":"Goetz","year":"2013","journal-title":"ACS Med. Chem. Lett"},{"key":"68","doi-asserted-by":"crossref","first-page":"e00498","DOI":"10.7554\/eLife.00498","article-title":"Pharmacological brake-release of mRNA translation enhances cognitive memory","volume":"2","author":"Hann","year":"2013","journal-title":"Elife"},{"key":"69","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/onc.2015.233","article-title":"Comprehensive translational control of tyrosine kinase expression by upstream open reading frames","volume":"35","author":"Leutz","year":"2016","journal-title":"Oncogene"},{"key":"70","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1158\/2159-8290.CD-13-0945","article-title":"Epithelial-to-mesenchymal transition activates PERK-eIF2alpha and sensitizes cells to endoplasmic reticulum stress","volume":"4","author":"Gupta","year":"2014","journal-title":"Cancer Discov"},{"key":"71","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1242\/jcs.095422","article-title":"E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells","volume":"125","author":"Kim","year":"2012","journal-title":"J. Cell. Sci"},{"key":"72","doi-asserted-by":"crossref","first-page":"e0132978","DOI":"10.1371\/journal.pone.0132978","article-title":"The crosstalk between Nrf2 and TGF-\u03b21 in the epithelial-mesenchymal transition of pancreatic duct epithelial cells","volume":"10","author":"Schafer","year":"2015","journal-title":"PLoS One"},{"key":"73","doi-asserted-by":"crossref","first-page":"E4036","DOI":"10.1073\/pnas.1512118112","article-title":"Molecular mechanism of the dual activity of 4EGI-1: dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1","volume":"112","author":"Leger-Abraham","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"74","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1432-1033.2004.04149.x","article-title":"Characterization of mammalian eIF4E-family members","volume":"271","author":"Jagus","year":"2004","journal-title":"Eur. J. Biochem"},{"key":"75","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/BST20150126","article-title":"Signalling to eIF4E in cancer","volume":"43","author":"Sonenberg","year":"2015","journal-title":"Biochem. Soc. Trans"},{"key":"76","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1182\/blood-2015-08-665679","article-title":"Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance","volume":"127","author":"Garcia-Sanz","year":"2016","journal-title":"Blood"},{"key":"77","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma","volume":"120","author":"Carpten","year":"2012","journal-title":"Blood"},{"key":"78","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V92.9.3025","article-title":"The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH\/MMSET hybrid transcripts","volume":"92","author":"Bergsagel","year":"1998","journal-title":"Blood"},{"key":"79","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1158\/1078-0432.CCR-11-0596","article-title":"The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma","volume":"17","author":"Neri","year":"2011","journal-title":"Clin Cancer Res"},{"key":"80","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"Epstein","year":"2007","journal-title":"Blood"},{"key":"81","article-title":"PROGgeneV2: enhancements on the existing database","volume":"14","author":"Nakshatri","year":"2014","journal-title":"BMC Cancer"},{"key":"82","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1182\/blood-2011-09-380410","article-title":"Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features","volume":"119","author":"Ngo","year":"2012","journal-title":"Blood"},{"key":"83","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbrc.2014.10.086","article-title":"The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin \u03b21-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway","volume":"454","author":"Kuroki","year":"2014","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"84","doi-asserted-by":"crossref","first-page":"E51","DOI":"10.3390\/jcm5050051","article-title":"Tumor Budding: The name is EMT","volume":"5","author":"Levine","year":"2016","journal-title":"Partial EMT J. Clin. Med"},{"key":"85","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2016.03.026","article-title":"Tight junction protein 1 modulates proteasome capacity and proteasome inhibitor sensitivity in multiple myelomaEGFR\/JAK1\/STAT3 signaling","volume":"29","author":"Crowley","year":"2016","journal-title":"Cancer Cell"},{"key":"86","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Neilson","year":"2009","journal-title":"J. Clin. Invest"},{"key":"87","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1523\/JNEUROSCI.1683-07.2007","article-title":"Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury","volume":"27","author":"Dash","year":"2007","journal-title":"J Neurosci"},{"key":"88","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1073\/pnas.1303058110","article-title":"EGF shifts human airway basal cell fate toward a smoking-associated airway epithelial phenotype","volume":"110","author":"Crystal","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"89","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1006\/bbrc.2000.3731","article-title":"Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3","volume":"277","author":"Wang","year":"2000","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"90","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.1158\/1078-0432.CCR-05-0523","article-title":"The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype","volume":"11","author":"Yaccoby","year":"2005","journal-title":"Clin Cancer Res"},{"key":"91","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/blood-2012-06-436220","article-title":"Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma","volume":"121","author":"Yarranton","year":"2013","journal-title":"Blood"},{"key":"92","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccr.2013.08.009","article-title":"Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma","volume":"24","author":"Tiedemann","year":"2013","journal-title":"Cancer Cell"},{"key":"93","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","article-title":"Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation","volume":"117","author":"Yuan","year":"2011","journal-title":"Blood"},{"key":"94","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/1535-7163.MCT-12-1151","article-title":"Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model","volume":"12","author":"Myers","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"95","doi-asserted-by":"crossref","first-page":"29854","DOI":"10.1074\/jbc.M115.664953","article-title":"The nuclear factor (erythroid-derived 2)-like 2 and proteasome maturation protein axis mediate bortezomib resistance in multiple myeloma","volume":"290","author":"Orlowski","year":"2015","journal-title":"J. Biol. Chem"},{"key":"96","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1158\/0008-5472.CAN-09-4428","article-title":"Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib","volume":"70","author":"Garcia","year":"2010","journal-title":"Cancer Res"},{"key":"97","first-page":"e27245","article-title":"Cap dependent translation contributes to resistance of myeloma cells to bortezomib","volume":"1","author":"Biffo","year":"2013","journal-title":"Translation (Austin)"},{"key":"98","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3892\/ijo.2014.2774","article-title":"Multiple myeloma proteostasis can be targetedtranslation initiation factor eIF4E","volume":"46","author":"Drucker","year":"2015","journal-title":"Int. J. Oncol"},{"key":"99","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.102","article-title":"Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism","author":"Driessen","year":"2016","journal-title":"Leukemia"},{"key":"100","doi-asserted-by":"crossref","first-page":"1000e110","DOI":"10.4172\/2157-7633.1000e110","article-title":"The cancer stem cell conundrum in multiple myeloma","volume":"2","author":"Hawley","year":"2012","journal-title":"J. Stem Cell Res. Ther"},{"key":"101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-\u03baB pathway in multiple myeloma","volume":"12","author":"Zhu","year":"2007","journal-title":"Cancer Cell"},{"key":"102","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4161\/auto.29456","article-title":"MAPK14\/p38\u03b1-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation","volume":"10","author":"Ciriolo","year":"2014","journal-title":"Autophagy"},{"key":"103","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-14-1088","article-title":"Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin","volume":"21","author":"Shanmugam","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:05:17Z","timestamp":1749578717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,10]]},"references-count":103,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,10,11]]}},"alternative-id":["11960","27626179"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11960","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,10]]}}}